LifePoint Health Inc (NASDAQ:LPNT) has received a consensus recommendation of “Hold” from the twenty-two brokerages that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, fifteen have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $57.64.
LPNT has been the topic of a number of recent analyst reports. Robert W. Baird set a $55.00 price target on LifePoint Health and gave the company a “buy” rating in a report on Monday, October 30th. Citigroup reduced their target price on LifePoint Health from $70.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, October 30th. SunTrust Banks set a $60.00 target price on LifePoint Health and gave the stock a “hold” rating in a report on Thursday, October 12th. KeyCorp reaffirmed a “hold” rating on shares of LifePoint Health in a report on Sunday, October 29th. Finally, Mizuho set a $50.00 target price on LifePoint Health and gave the stock a “hold” rating in a report on Friday, October 27th.
In related news, Director Marguerite Kondracke sold 3,416 shares of LifePoint Health stock in a transaction dated Tuesday, November 21st. The stock was sold at an average price of $43.80, for a total value of $149,620.80. Following the completion of the transaction, the director now owns 17,479 shares in the company, valued at $765,580.20. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider David M. Dill sold 45,000 shares of LifePoint Health stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $48.52, for a total value of $2,183,400.00. Following the completion of the transaction, the insider now owns 252,673 shares of the company’s stock, valued at approximately $12,259,693.96. The disclosure for this sale can be found here. In the last quarter, insiders sold 52,323 shares of company stock valued at $2,507,781. 8.76% of the stock is currently owned by company insiders.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in LPNT. Wells Fargo & Company MN grew its position in LifePoint Health by 2.0% in the second quarter. Wells Fargo & Company MN now owns 22,394 shares of the company’s stock worth $1,504,000 after acquiring an additional 443 shares in the last quarter. Teachers Advisors LLC boosted its position in shares of LifePoint Health by 1.3% during the second quarter. Teachers Advisors LLC now owns 65,909 shares of the company’s stock valued at $4,426,000 after buying an additional 836 shares during the period. Ameriprise Financial Inc. boosted its position in shares of LifePoint Health by 5.5% during the second quarter. Ameriprise Financial Inc. now owns 118,101 shares of the company’s stock valued at $7,931,000 after buying an additional 6,116 shares during the period. Thrivent Financial For Lutherans boosted its position in shares of LifePoint Health by 7.4% during the second quarter. Thrivent Financial For Lutherans now owns 8,130 shares of the company’s stock valued at $546,000 after buying an additional 560 shares during the period. Finally, Vanguard Group Inc. boosted its position in shares of LifePoint Health by 1.3% during the second quarter. Vanguard Group Inc. now owns 3,310,467 shares of the company’s stock valued at $222,299,000 after buying an additional 43,504 shares during the period.
LifePoint Health (NASDAQ LPNT) remained flat at $$46.85 during trading hours on Friday. 56,110 shares of the stock were exchanged, compared to its average volume of 522,756. The company has a quick ratio of 1.65, a current ratio of 1.85 and a debt-to-equity ratio of 1.24. The firm has a market capitalization of $1,907.72, a P/E ratio of 11.03, a PEG ratio of 1.11 and a beta of 0.52. LifePoint Health has a twelve month low of $42.50 and a twelve month high of $70.95.
LifePoint Health declared that its board has approved a stock buyback program on Friday, October 27th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s management believes its stock is undervalued.
TRADEMARK VIOLATION WARNING: “LifePoint Health Inc (LPNT) Receives Average Rating of “Hold” from Analysts” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another domain, it was illegally copied and republished in violation of international copyright legislation. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/02/16/lifepoint-health-inc-lpnt-receives-average-rating-of-hold-from-analysts.html.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.